Please note that this programme may be subject to change

Click on the buttons below to view the programme for each day and detailed programme of presentation timings

Registration

Registration and refreshments

0900-1000 hours
Entrance to President’s Lounge

Welcome

Welcome message from the APS Chair and opening of the PharmSci 2025 Conference
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

1000-1010 hours
Millennium Lounge

Science Chair
Lecture

“Pharmaceutical Sciences Driving the Next Generation Medicines”
Dr Marianne Ashford, Senior Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca

1010-1050 hours
Millennium Lounge

Plenary Lecture

“Promoting Cancer Nanomedicine Clinical Translation”
Professor Twan Lammers, PhD, DSc, Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohybrid Medical Systems, RWTH Aachen University Clinic, Germany

1050-1135 hours
Millennium Lounge

Exhibitors Showcase

Quick fire presentations from our PharmSci 2025 Exhibitors

• Centrix Pharma Solutions
• Friedheim Scientific
• Genvolt
• Hiden Isochema
• Intertek
• MDPI
• MeltPrep
• Pion

1135-1205 hours
Millennium Lounge

Parallel Science Session 1
1400-1530 hours

Skin Forum
“Overcoming the skin barrier: physical and computational approaches”

Session Chair: Professor James Birchall, Professor of Pharmaceutical Sciences and Deputy Head of School, School of Pharmacy and Pharmaceutical Sciences,
Cardiff University, Wales, UK
Room: St David’s Lounge

Advanced Therapy & Medicinal Products Focus Group

Session Chair: Dr Zahra Rattray (MPharm, PhD, FHEA, FAPS, MRSC, FRPharmS), Reader in Translational Pharmaceutics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK
Room: Millennium Lounge

Session Chair: Purav Shah, (M.Sc. (Hons), B. Pharm), Chief Scientific Officer, Thoroughbred Remedies Manufacturing. TRM, Ireland
Room: The Clubhouse

“Microneedles for Vaccines and topical drug delivery“
Dr Faz Chowdhury, CEO, Landmark Vaccines Limited, Loughborough, UK

“Molecular Simulations of Skin-Lipid Membranes and Drug Permeability Enhancement”
Dr Rebecca Notman, Associate Professor in Computational Biochemistry, School of Biochemistry, University of Bristol, UK

Podium presentations from abstract submissions

“Advanced Biofunctional Nanocarriers for Effective Topical Therapy in Combination with Cold Plasma: A MultiTargeted Approach to Alleviate Psoriasis”
Yashika Tomar, Ph.D. Research Scholar, Department of Pharmacy, Birla Institute of Technology & Science (BITS) Pilani, Rajasthan, India

“Natural Polymer Hydrogels for Microneedle Assisted Delivery of Drugs with Different Polarities and Molecular Weights”
Boyan Wang, Postgraduate Researcher, School of Pharmacy, Queen’s University Belfast, UK

“Optimising the Interface between Medical Devices and Soft Tissue for the Delivery of Biologics and Cell-based Therapies”
Dr Eoin O’Cearbhaill, Associate Professor of Biomedical Engineering, Director of the UCD Centre for Biomedical Engineering, School of Mechanical & Materials Engineering,
UCD, Ireland

“Microparticles to improve cell engraftment and transplant niche control”
Dr Lisa White, Associate Professor in Biomaterials and Regenerative Medicine, University of Nottingham

“Rationalising mAb developability testing”
Dr Leon F Willis MRSC, Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, UK

Podium presentations from abstract submissions

“Inhalable Immunoliposomes as a Novel Therapeutic Strategy for SARS-CoV-2: From Formulation to Preclinical Testing in a
COVID-19 Model”
Nur Dini Fatini Mohammad Faizal, National University of Malaysia, Malaysia

“Modulation of Doxorubicin Encapsulation Efficiency and Physicochemical Properties of Silk Nanoparticles by Calcium Ion Interaction”
Napaporn Roamcharern, University of Strathclyde, UK

“Highly lipophilic prodrugs of PD-1/PD-L1 inhibitor BMS-1 for targeted delivery to mesenteric lymph nodes”
Yunfei Zhong, University of Nottingham, UK

“Air-Liquid Interface Organ-on-Chip Models: Advancing Drug Development
for Barrier Tissues”
Dr Prajakta Dandekar Jain, UGC Assistant Professor in Engineering Sciences, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (ICT), Mumbai, India

“In vitro tools for testing of non-oral complex formulations”
Samir Haddouchi, Managing Director, SOTAX Pharma Services, France

“Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated
in-vitro/in-silico approach”
Dr Belal Hanafy, Senior Scientist, Pharmaceutical Sciences, Advanced Drug Delivery, AstraZeneca UK

Podium presentations from abstract submissions

“Improving PROTAC Dissolution via an Ionic Liquid API Approach with Enhanced Solid Handling”
Patrick Keady, School of Chemical and Bioprocess Engineering, University College Dublin, UK

“Building a Control Strategy for Nitrosamine Formation: A Case Study Using ASAPprime® Modelling in Drug Product Development”
Michele Ghirardi, Head of Pharmaceutical Sciences, Centrix Pharma Solutions

“Dissolving PVP Microneedles for Rapid Transdermal Delivery: Fluorescein as a Model Marker”
Sirirat Sriraksa, PhD Student, School of Chemistry, Food and Pharmacy, University of Reading, UK

Parallel Science Session 2
1600-1730 hours

Our thanks to PCI Pharma Services who have kindly sponsored this
Parallel Science Session.

To find out more about PCI Pharma Services please take a look at our
Exhibitors and Sponsors Page or click here to visit the PCI Pharma Services website.

Biopharmaceutics Focus Group – “Biopharmaceutics challenges with complex delivery of oral molecule”

Session Chair: Chris Roe, Senior Research Fellow, Scientific Consulting, Quotient Sciences, UK and Dr Deirdre M. D’Arcy, Associate Professor in Pharmaceutics and Pharmaceutical Technology, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin
Room: Millennium Lounge

Drugs from Natural Sources Focus Group
“The Next Generation of (Herbal) Medicines – Sustainability meets Drug Development”

Session Chair: Dr Suky Bhamra, Senior Lecturer in Pharmacy Clinical and Professional Practice, Medway School of Pharmacy, University of Kent, UK and Professor Michael Heinrich, Research Group ‘Pharmacognosy and Phytotherapy’, UCL School of Pharmacy, University College London , UK
Room: St David’s Lounge

Emerging Technologies Focus Group
“Translational applications of 3D printing of medicines in clinical settings”

Session Chair: Dr Atheer Awad, Lecturer in Pharmaceutics, University of Hertfordshire, UK
Room: The Clubhouse

“Formulation approaches for oral peptide administration: which strategies
are most promising”
David Brayden, Ph.D., FAAPS, MRIA, Professor of Advanced Drug Delivery, Veterinary Sciences Centre, University College Dublin, Ireland

“GLP1 agonist/ GIPR agonist industry lessons learned with respect to biopharmaceutics of these peptide compounds“
Omid Arjmandi-Tash, Principal Scientist, Pfizer, UK

“Modelling the effect of a permeability enhancer on the absorption of
a poorly permeable large
molecule: A retrospective analysis”
Dr Ricardo Diaz de Leon Ortega, Modelling and Simulation Research Fellow, Quotient Sciences, UK

“Physiologically Based Biopharmaceutics Model (PBBM) Report Template: Considerations for Improved Quality in View of Regulatory Submissions“
Dr Mark McAllister, Chief Scientific Officer, Biowaived, UK

Podium presentations from abstract submissions

“Application of cocrystal fundamentals to extend drug supersaturation lifetime during cocrystal dissolution“
Lucy May Newman,
Newcastle University, UK

“Advanced measurement and modelling of particle size and shape data for PK predictions“
Maiara C. Montanha,
Bristol Myers Squibb, UK

“Future-Proof Medicine: The Evolving Role Of Sustainability In Research & Development”
Dr Gaia A. Scalabrino, NatPro Executive Director, NatPro Trinity Centre for Natural Products Research, Trinity College Dublin, Ireland

“Conservation and sustainable use of medicinal plants: How do they pay into our SDG compliance?“
Dr Olaf Kelber, Scientific Strategy Phytomedicines, Bayer Distinguished Science Fellow, Research and Development, Phytomedicines Supply and Development Center, Bayer Consumer Health, Germany

Podium presentations from abstract submissions

“Development and Evaluation of Nephroprotective Potential of Combined Extract of Punica granatum L and Piper cubeba L against Diclofenac Induced Nephrotoxicity: In vitro and In vivo approaches“
Hamad Ali, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

“Implementation of 3D-printing into a hospital’s closed-loop medication management system”
Dr Adrin Dadkhah, Hospital Pharmacy and Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf, Germany

“Clinical implementation of 3D printing in hospitals and pharmacies”
Dr Alvaro Goyanes, CEO and Co-founder, FABRX Limited, UK

“Commercial medication in 3D printed medicines – Source what you have”
Julian Quodbach, PhD, Assistant Professor, Division of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences

Podium presentations from abstract submissions

“Integrating Sensors in Pessaries: A Step Toward Intelligent Women’s Health Solutions”
Lisa Kuchler, PhD Student, Research Center for Pharmaceutical Engineering (RCPE), Austria

“Development of sustained-release gastro-floating drug delivery system for metformin hydrochloride via semisolid extrusion 3d printing”
Dr Prof. Dongwuk Kim, College of Pharmacy, Kyungpook National University, South Korea

“Programmable 3D Printed Conductive Polymers for Releasing Neutrally-Charged Drugs”
Dr Manal Alkahtani, Assistant Professor of Pharmaceutics, Department of Pharmaceutics, College of Pharmacy, PSAU, SA

“A semi-automated method for accelerated prediction of new micellar nanomedicines”
Antonia Gucic, UCL School of Pharmacy, UK

Poster Session

Opportunity to view posters and network with presenters

Registration

Registration and refreshments

0830-0900 hours
Entrance to President’s Lounge

Welcome

Welcome from the APS Chair
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

0900-0905 hours
Millennium Lounge

Presentation

Presentation by SAPS (Students of Academy of Pharmaceutical Sciences)
Hadassah Anyanwu, University of Greenwich, UK and Charlotte Oliver, Queen’s University Belfast, UK

0905-0915 hours
Millennium Lounge

Plenary Lecture

“The RNA Revolution: From Vaccines to Therapeutic Genome Editing in a Targeted Manner”
Professor Dan Peer, Director, Laboratory of Precision NanoMedicines, Tel Aviv University, Israel

0915-1000 hours
Millennium Lounge

Award

Presentation of APS Innovative Science Medal Award
Sponsored by:

1000-1005 hours
Millennium Lounge

Award Lecture

“Small things can have big effects – manipulating cell signalling through nanoplatforms”
Professor Chris Scott, Chair of Pharmaceutical Biosciences, Dean of Research, Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast, Ireland

1005-1040 hours
Millennium Lounge

Parallel Science Session 1
1100-1230 hours

Our thanks to Pharmaron who have kindly sponsored this Parallel Science Session.

To find out more about Pharmaron please take a look at our Exhibitors and Sponsors Page
or click here to visit the Pharmaron website.

Process Engineering Focus Group

Session Chair: Charlotte Cartwright, Senior Compaction Scientist, Merlin Powder Characterisation, UK
Room: St David’s Lounge

New Scientist Focus Group

Session Chairs: Dr Kofi Asare-Addo, Reader in Pharmaceutics, Admissions Tutor for Pharmacy (MPharm), University of Huddersfield, UK and Dr Nihad Mawla, University of Huddersfield, School of Applied Sciences, Department of Pharmacy, UK
Room: Millennium Lounge

Joint Pharmaceutical Analysis Group (JPAG)

Session Chair: Professor Laura Waters, University of Huddersfield, UK
Room: The Clubhouse

“Don’t believe the hype : D&D implementation at Novartis”
Dr Sarah David, Scientific Advisor, Pharmaceutical Development,
Novartis, Basel

Podium presentations from abstract submissions

“From Lab to Life: crafting an academic career in Pharmaceutical Sciences”
Dr Sara Cordeiro, Senior Lecturer in Pharmaceutics, MPharm Director, Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, UK

“Bath, BMS and Beyond: A Career in Pharmaceutical Science“
Mike Tobyn, PhD, Senior Scientific Director, Materials Science and Engineering, Bristol Myers Squibb, UK

Podium presentations from abstract submissions

“Design of lipid nanoparticles for messenger RNA therapy by repurposing of ‘lipid-like’ cationic amphiphilic drugs“
Aliona Debisschop, PhD Student , Department of Pharmaceutics, Ghent University, Belgium

“To Boost or Not to Boost: Evaluating the Impact of Dose Interval on Immune Response in Mice“
Rebecca Macfarlane, PhD Student, Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, UK

“Gene delivery of nucleic acid therapy targeting MAPT for the treatment of Alzheimer’s disease“
Xinai Shen, School of Pharmacy, University of Nottingham, NG7 2RD, Nottingham, UK

“Impact of PEO Molecular Weight on Electrospun PVA Nanofibers for Controlled Drug Delivery“
Rand Abdulhussain, PhD Researcher, Department of Pharmacy, University of Huddersfield, UK

“Exploring Electrical Asymmetric Flow Field-Flow Fractionation for Analysing the Nanoparticle Protein Corona“
Miss Panida Punnabhum, University of Strathclyde, UK

“Advanced Analytics: Developability assessment of new modality therapeutics”
Dr Zahra Rattray, Reader in Translational Pharmaceutics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK

“Sustainable analytics for New Modality Therapeutics”
Professor Paul Ferguson, Principal Scientist, AstraZeneca, UK

“Biosensors for Forensic Analysis”
Maxine den Hartog, PhD Candidate, King’s Forensic Biochemistry Group, King’s College London, UK

Podium presentations from abstract submissions

“Using Co-Amorphous System to Stabilise Amorphous Flufenamic acid Form I Produced by a Quench-Cool Method”
Shifaa Alabrash, University of Surrey, UK

Parallel Science Session 2
1400-1530 hours

Nanomedicines Focus Group
“Nanomedicine to enhance
next-generation therapies”

Session Chair: Professor Elaine Ferguson, Professor in Polymer Therapeutics, School of Dentistry, Cardiff University, UK and Professor Philipp Seib, Friedrich Schiller University Jena, Germany
Room: St David’s Lounge

Regulatory Focus Group

Session Chair: Colm Reddington, Senior Director CMC Regulatory Affairs, AstraZeneca, UK
Room: Millennium Lounge

“Highlights from Posters”

Session Chair: Dr Esther Jacobs, Associate Principal Scientist, AstraZeneca, UK and Dr Sara Cordeiro, Senior Lecturer in Pharmaceutics, MPharm Director, Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, UK
Room: The Clubhouse

“Deep Diving into Endocytic Pathways to Unravel the Delivery Efficiency of Nanomedicines”
Arwyn T. Jones, Professor of Membrane Traffic and Drug Delivery, School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Wales, UK

Podium presentations from abstract submissions

“How AI will influence the future of medicine development and manufacture”
Professor Alastair Florence, Director, CMAC, University of Strathclyde, UK

“Industry Case Study – Improving product quality with AI during visual inspection”
Matt Popkin, Executive Director, CMC Excellence, CMC Regulatory Affairs, GSK, UK

“Industry Case Study – Machine Learning in Stability Analysis & how AI will influence in the future”
Luke Scrivens (MChem), Associate Principal Scientist for Predictive Stability, AstraZeneca UK Ltd, Global Product Development, UK

“Regulating for the AI future”
Dr Bassel Odeh, Head of New Active Substances Team, Medicines & Healthcare Products Regulatory Agency, UK

“Cyclodextrin-based nanoparticles for oral delivery of RNA-therapies in ileal Crohn’s disease”
Miss Francisca Soares, PhD candidate, University College Cork, UK

“Application of HT-PBPK Modelling for developing an IVIVE of Oral Permeability in OSPsuite”
Mariana Guimarães, Senior PBPK Scientist, ESQlabs GmbH, Germany

“The Great Escape – Defining the Molecular Basis of Cellular Uptake and Endosomal Escape of Antibody Drug Conjugates”
Harriet Graham, University of Strathclyde, UK

“Hydrogel-forming Microneedles for Biosensing and Therapeutic Drug Monitoring Incorporated with Moisture-Indicating Silica Baseplate“
Donal Greene, Queen’s University Belfast, UK

“Design, fabrication, and optimization of mometasone furoate-loaded nanostructured lipid carriers for topical delivery”
Promise Ayomide Adekola, PhD Researcher, Department of Pharmacy, University of Huddersfield, UK

“Stability testing of a paediatric moxidectin formulation“

“Comparison of USP2 and USP4 dissolution profiles with TIM-2 using F1/F2 metrics”
Miss Khushi Khandelwal, University of Strathclyde, UK

“Encapsulation of Moringa oleifera Seed Extract in PLGA Nanoparticles Enhances Bioactivity in Liver Cell Model”
Boluwatife Sowunmi, University of Greenwich, UK

“Printing the future of vaccines”
Krystian Lewandowski, PhD Student, University of Nottingham, UK

Award

Presentation of APS Academy Medal Award
Sponsored by:

1600-1605 hours
Millennium Lounge

Plenary Lecture

Presentation by APS Academy Medal Award Winner
“Designing and translating new biomaterials for therapeutics and disease detection”
Professor Dame Molly Stevens DBE FRS FREng, John Black Professor of Bionanoscience, University of Oxford and a part-time Professor, Imperial College London and the Karolinska Institute, UK

1605-1650 hours
Millennium Lounge

Registration

Registration and refreshments

0830-0900 hours
Entrance to President’s Lounge

Welcome

Welcome from the APS Chair
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

0900-0902 hours
Millennium Lounge

Award

Presentation of APS Award

Sponsored by:

0902-0905 hours
Millennium Lounge

Award Lecture

Presentation by APS Award Winner
“Using the very small to tackle the very large – our journey from concept to clinic”
Professor Dame Ijeoma Uchegbu DBE FMedSci HonFRSC, President, Wolfson College, University of Cambridge, UK

0905-0950 hours
Millennium Lounge

Award

Presentation of APS Emerging Scientist Award
Sponsored by:

0950-0955 hours
Millennium Lounge

Award Lecture

Presentation by APS Emerging Scientist Award Winner
“Nanovaccines for Brain Cancer: Advancing Immunotherapy Through Precision Drug Delivery”
Dr Flávia Sousa, Assistant Professor at Groningen Research Institute of Pharmacy, University of Groningen, Netherlands

0955-1030 hours
Millennium Lounge

Parallel Science Session 1
1130-1300 hours

Our thanks to Norbrook who have kindly sponsored this Parallel Science Session.

To find out more about Norbrook please take a look at our Exhibitors and Sponsors Page
or click here to visit the Norbrook website.

Biopharmaceutics Focus Group
“Biopharmaceutics challenges with complex delivery of new modalities”

Session Chair: Chris Roe, Senior Research Fellow, Scientific Consulting, Quotient Sciences, UK and Dr Deirdre M. D’Arcy, Associate Professor in Pharmaceutics and Pharmaceutical Technology, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin
Room: Millennium Lounge

Material Science Focus Group

Session Chair: Dr Simon Roberts, Controlled Release Manager – EMEA, IMCD UK Limited, UK
Room: St David’s Lounge

Inhaled

Session Chair: Sara Pinto, Business Development Manager, Intertek Melbourn, UK
Room: The Clubhouse

“Considerations and opportunities for the oral delivery of peptides and oligonucleotides“
Dr Nigel Davies, (BPharm, MRPHarmS, PhD), Senior Principal Scientist in Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Sweden

“Current landscape on the complexities associated with the delivery of long-acting drug formulations and long-acting injectables which may impact biopharmaceutics“
Professor Neill Liptrott, Chair in Pharmacology and Immunocompatibility, Department of Pharmacology and Therapeutics, University of Liverpool, UK

“Can we predict the bioavailability of monoclonal antibodies after subcutaneous dosing? A physiologically based pharmacokinetic modelling study“
Dr Felix Stader PhD, Certara Predictive Technologies, UK

Podium presentations from abstract submissions

“Hydrogel-Forming Microneedles for Vancomycin Delivery Using an Effervescent Tablet Reservoir“
Lutfi M. Alzuraiqi, PhD Student, School of Pharmacy, Queen’s University Belfast, UK

“Minimally Invasive Delivery of a Novel Potent Anti[1]Inflammation SoloMER Biologic Using Microarray Patches”
Miss Malina Tofan, Queen’s University Belfast, UK

“Oral administration of seeds-derived oleosomes formulation facilitate intestinal lymphatic transport and immunomodulatory effect of cannabidiol“
Yufei Zhu, School of Pharmacy, University of Nottingham, UK

“Development of long-acting therapeutics: Challenges and opportunities“
Dr James Hobson, Research Coordinator, Centre for Excellence in Long-acting Therapeutics, University of Liverpool, UK

“Macromolecules: From Advanced Drug Delivery Systems to Precision Designed Actives“
Kevin Treacher, Principal Scientist, Global Product Development, Pharmaceutical Technology & Development, AstraZeneca, UK

Podium presentations from abstract submissions

“Printing the future of vaccines“
Krystian Lewandowski, PhD Student, University of Nottingham, UK

“Unlocking the Positional Puzzle: Mechanochemical Exploration of Sulfa Drug-Coformer Interactions“
Anna Ryan, Panoz Institute, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, UK

“Inhaled RNA therapy – bridging the current gaps“
Dr Jenny Lam, Associate Professor of Pharmaceutics,
UCL School of Pharmacy, UK

“Applying the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products“
Professor Ben Forbes, Head of Institute of Pharmaceutical Science, King’s College London, UK

“Sustainable Inhalation Therapies: Strategies for Reducing the Carbon Footprint in Pharmaceutical Delivery Systems“
Kellisa Lachacz, Principal Scientist, AstraZeneca, UK

Award

Presentation of Poster Awards

1300-1330 hours
Millennium Lounge

Close

Concluding remarks from APS Chair and close of Conference
Professor Ryan Donnelly, APS Chair and Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast

1330-1340 hours
Millennium Lounge

If you have any questions please send us an email to info@apsgb.co.uk and one of our team will come back to you.